Goat anti-mouse IgG F(ab’)2 Fragment

Product Description

Goat anti-mouse IgG F(ab’)2 Fragment
Catalog number: B2010254
Lot number: Batch Dependent
Expiration Date: Batch dependent
Volume/Weight: 0.250 mL
pH: 7.4
Supplied as: Ready-to-use
Appearance: Solution
Applications: high purity unconjugated IgG F(ab’)2 Fragment specific to Fab. This product is suitable for many immuno-applications such as ELISA.
Storage: -20C
Keywords: anti-IgG antibody
Grade: Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered on a 0.22 um.

References:
1: Bush SP, Ruha AM, Seifert SA, Morgan DL, Lewis BJ, Arnold TC, Clark RF, Meggs
WJ, Toschlog EA, Borron SW, Figge GR, Sollee DR, Shirazi FM, Wolk R, de Chazal
I, Quan D, García-Ubbelohde W, Alagón A, Gerkin RD, Boyer LV. Comparison of
F(ab’)2 versus Fab antivenom for pit viper envenomation: a prospective, blinded,
multicenter, randomized clinical trial. Clin Toxicol (Phila). 2015
Jan;53(1):37-45.

2: Bellaye PS, Moreau M, Raguin O, Oudot A, Bernhard C, Vrigneaud JM, Dumont L,
Vandroux D, Denat F, Cochet A, Brunotte F, Collin B. Radiolabeled
F(ab’)₂-cetuximab for theranostic purposes in colorectal and skin
tumor-bearing mice models. Clin Transl Oncol. 2018 Dec;20(12):1557-1570.

3: Rosenstein S, Vaisman-Mentesh A, Levy L, Kigel A, Dror Y, Wine Y. Production
of F(ab’)₂ from Monoclonal and Polyclonal Antibodies. Curr Protoc Mol
Biol. 2020 Jun;131(1):e119.

4: Valedkarimi Z, Nasiri H, Aghebati-Maleki L, Abdolalizadeh J, Esparvarinha M,
Majidi J. Production and characterization of anti-human IgG F(ab’)2 antibody
fragment. Hum Antibodies. 2018;26(4):171-176.

5: Cui Z, Li D, Yi S, Guo Y, Dong G, Niu J, Zhao H, Zhang Y, Zhang S, Cao L,
Wang K, Zhao Y, Hu G. Equine immunoglobulin F(ab’)₂ fragments protect
cats against feline calicivirus infection. Int Immunopharmacol. 2019
Oct;75:105714.

6: Li Q, Peterson N, Hanna RN, Kuszpit K, White J, Allen KL, Barnes A, Rickert
KW, Shan L, Wu H, Dall’Acqua WF, Tsui P, Borrok MJ. Antibody Fragment
F(ab’)₂ Targeting Caveolae-Associated Protein PV1 for Selective
Kidney Targeting and Retention. Mol Pharm. 2020 Feb 3;17(2):507-516.

7: Squaiella-Baptistão CC, Magnoli FC, Marcelino JR, Sant’Anna OA, Tambourgi DV.
Quality of horse F(ab’)₂ antitoxins and anti-rabies immunoglobulins:
protein content and anticomplementary activity. J Venom Anim Toxins Incl Trop
Dis. 2018 Jun 18;24:16.

8: Reveneau E, Cottin P, Rasuli A. Two decades of pharmacovigilance and clinical
experience with highly purified rabies immunoglobulin F(ab’)₂
fragments. Expert Rev Vaccines. 2017 Mar;16(3):273-287.

9: Lasoff DR, Ruha AM, Curry SC, Koh C, Clark RF. A new F(ab’)₂
antivenom for the treatment of crotaline envenomation in children. Am J Emerg
Med. 2016 Oct;34(10):2003-2006.

10: Canul-Caamal MA, Madrigal-Anaya JDC, Pastelin-Palacios R, Escalante-Galindo
P, Moreno-Eutimio MA. Cryotherapy as a coadjuvant in crotaline snakebite
management with F(ab’)₂ antivenom: A randomized pilot study. Complement Ther Med. 2020 Nov;54:102569.

Products Related to Goat anti-mouse IgG F(ab’)2 Fragment: Antibodies